Whitehead Institute for Biomedical Research-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Whitehead Institute for Biomedical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014005
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Whitehead Institute for Biomedical Research (Whitehead Institute), a subsidiary of Massachusetts Institute of Technology is a non-profit research and educational institute that offers technologies to improve human health. The institute undertakes the development of therapies for diseases that include alzheimer’s, parkinson’s, diabetes and other cancers. It provides programs in developmental biology, stem cell research, cancer research, immunology, regenerative medicine, genetics and genomics-programs. Whitehead has affiliation with Massachusetts Institute of Technology in its teaching activities to provide intellectual, collegial and scientific benefits of the research university. Whitehead Institute is headquartered in Cambridge, Massachusetts, the US.

Whitehead Institute for Biomedical Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research 10
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 11
White Head Institute And Biogen Idec Enter Into Reasearch Agreement 12
Licensing Agreements 13
Syros Pharma Enters into Licensing Agreement with Whitehead Institute 13
Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 14
Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research 16
Whitehead Institute for Biomedical Research – Key Competitors 17
Whitehead Institute for Biomedical Research – Key Employees 18
Whitehead Institute for Biomedical Research – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Government and Public Interest 21
Dec 26, 2016: Naturally occurring mechanism of cancer drug-resistance may itself be a treatment target 21
Feb 18, 2016: B-cell diversity in immune system’s germinal centers may be key to broad-spectrum vaccines 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Key Facts 2
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Whitehead Institute for Biomedical Research, Deals By Therapy Area, 2011 to YTD 2017 8
Whitehead Institute for Biomedical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research 10
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 11
White Head Institute And Biogen Idec Enter Into Reasearch Agreement 12
Syros Pharma Enters into Licensing Agreement with Whitehead Institute 13
Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 14
Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research 16
Whitehead Institute for Biomedical Research, Key Competitors 17
Whitehead Institute for Biomedical Research, Key Employees 18

★海外企業調査レポート[Whitehead Institute for Biomedical Research-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd is an upstream oil and gas exploration and production company that explores, produces, and develops, oil and gas properties in Trinidad and Tobago. The company holds interests, owns, and operates projects such as WD-4 …
  • Mediclin AG (MED):企業の財務・戦略的SWOT分析
    Summary Mediclin AG (Mediclin) is a healthcare service provider that provides rehabilitation and medical care services. The center provides services in neuro-medicine with neurology, early neurological rehabilitation, neurosurgery and neuroradiology and psychological sciences, among others. It also …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • United Technologies Corp (UTX):企業の財務・戦略的SWOT分析
    United Technologies Corp (UTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Clientele Limited
    Clientele Limited - Strategy, SWOT and Corporate Finance Report Summary Clientele Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Energisa SA (ENGI11):企業の財務・戦略的SWOT分析
    Energisa SA (ENGI11) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aveda Transportation and Energy Services Inc (AVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Aveda Transportation and Energy Services Inc (Aveda), formerly Phoenix Oilfield Hauling Inc is an oilfield service provider that offers energy transportation and other energy related services. The company provides specialized transportation services and equipment for drilling, exploration, d …
  • Inretail Peru Corp.:企業の戦略的SWOT分析
    Inretail Peru Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ecolab Inc.:企業の戦略・SWOT・財務分析
    Ecolab Inc. - Strategy, SWOT and Corporate Finance Report Summary Ecolab Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Venado Oil & Gas LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Venado Oil & Gas LLC (Venado) is an oil and gas company that offers oil and gas services. The company explores and develops oil and natural gas properties in the Gulf Coast and Permian regions of Texas. It also provides crude oil and natural gas products. Venado offers services such as execu …
  • Emlin Cosmetics :企業の戦略・SWOT・財務情報
    Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report Summary Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ability Pharmaceuticals SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly AB Therapeutics SL is a biopharmaceutical company that discovers and develops human therapeutics for the treatment of cancer and other indications. The company’s lead pipeline drug candidate includes ABTL0812, a new drug class of small mo …
  • Sundance Energy Australia Ltd (SEA):企業の財務・戦略的SWOT分析
    Summary Sundance Energy Australia Ltd (Sundance Energy Australia) is an onshore oil and gas exploration company that offers acquisition, exploration, production, operations, management, and development of crude oil and natural gas reserves. It develops projects in the Denver-Julesburg Basin located …
  • Caerus Oil and Gas LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Caerus Oil and Gas LLC (Caerus Oil and Gas) is an oil and gas exploration and development company that acquires, develops and produces natural gas and liquids. The company provides business activities such as acquiring conventional oil and gas production and reserves through asset and corpor …
  • Teledyne Technologies Incorporated (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Incorporated (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • State Bank of India:企業のM&A・事業提携・投資動向
    State Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's State Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Glow Energy Public Co Ltd:発電所・企業SWOT分析
    Glow Energy Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆